2024 in accordance with the notification of the SEC. DAB Act S.30 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 8/2025 Dated 26/06/2025

the criteria prescribed by the Securities and Exchange Commission. SEC Act S.97 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 92/2025 Dated 26/06/2025

199 Medical Clinic Company Limited 199 Medical Clinic Company Limited offered for sale of newly issued shares in the form of general or to the public without approval from the SEC office. SEC Act

level of care and diligence expected of a professional in safeguarding the interests of the bondholders. SEC Act S.46 Settlement Committee Meeting No. 10/2025 Settlement Committee Order No. 143/2025

program basis without providing its securities for credit rating prior to the offer for sale of the securities which is in violation of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement

securities in the category of promissory note without approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 6/2023

the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 7/2023 Settlement Committee Order No. 65/2023 Dated 09

submitted an incomplete registration statement (FORM 69-PP-PRICING) which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 7/2024 Settlement

the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 10/2024 Settlement Committee Order No. 106/2024 Dated 19/12/2024

approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 3/2025 Settlement Committee Order No. 40/2025 Dated 25/04/2025